SIBN

SI-BONE, Inc. - Common Stock (SIBN)

About SI-BONE, Inc. - Common Stock (SIBN)

SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.

Details

Daily high
$25.02
Daily low
$23.66
Price at open
$24.95
52 Week High
$25.92
52 Week Low
$11.48
Market cap
1.1B
Dividend yield
-
Volume
924,944
Avg. volume
874,874
P/E ratio
-80.74

SI-BONE, Inc. - Common Stock News

Details

Daily high
$25.02
Daily low
$23.66
Price at open
$24.95
52 Week High
$25.92
52 Week Low
$11.48
Market cap
1.1B
Dividend yield
-
Volume
924,944
Avg. volume
874,874
P/E ratio
-80.74